SUSAN S COURTNEY

Allopathic & Osteopathic Physicians|Family Medicine TUCSON, AZ NPI 1700840352

General Payments — all program years on this page

$1,428.80

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 85
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $362.93 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $362.9320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $223.1914
2019 $324.9622
2020 $175.7610
2021 $83.205
2022 $88.504
2023 $170.2610
2024 $362.9320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077917055 Janssen Pharmaceuticals, Inc $24.19 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086187420 Bayer Healthcare Pharmaceuticals Inc. $15.74 03/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086222618 Bayer Healthcare Pharmaceuticals Inc. $13.25 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086247858 Bayer Healthcare Pharmaceuticals Inc. $13.80 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096897548 Novo Nordisk Inc $14.10 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104364267 AstraZeneca Pharmaceuticals LP $14.27 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104532778 AstraZeneca Pharmaceuticals LP $17.54 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104581996 AstraZeneca Pharmaceuticals LP $15.86 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104607040 AstraZeneca Pharmaceuticals LP $13.96 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105471529 AstraZeneca Pharmaceuticals LP $19.13 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105504144 AstraZeneca Pharmaceuticals LP $14.93 08/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105548813 AstraZeneca Pharmaceuticals LP $17.50 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105736979 AstraZeneca Pharmaceuticals LP $44.31 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114623031 Exact Sciences Corporation $16.41 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114623035 Exact Sciences Corporation $22.36 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115533450 Amgen Inc. $23.42 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115533458 Amgen Inc. $13.50 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115533467 Amgen Inc. $17.68 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135351833 Lilly USA, LLC $15.72 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151051991 Phathom Pharmaceuticals, Inc. $15.26 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.